MET Form 4: 534 Shares Granted to Director; Ownership 33,351

Rhea-AI Filing Summary

Denise M. Morrison, identified as a director of MetLife, Inc. (MET), reported a non-derivative acquisition of 534 shares of MetLife common stock on 10/01/2025. The shares were issued as part of MetLife's non-management director compensation and recorded with a price of $0 (retainer paid in stock). Following the transaction the reporting person beneficially owned 33,351 shares. The Form 4 filing was signed on 10/03/2025 by an attorney-in-fact. The disclosure states these shares represent a portion of the director retainer paid in company stock.

Positive

• 534 shares acquired as director compensation on 10/01/2025
• Beneficial ownership increased to 33,351 shares
• Grant tied explicitly to non-management director retainer, indicating alignment with shareholders

Negative

• None.

Insights

Corporate Governance Analyst

Director received equity compensation aligning interests with shareholders.

This Form 4 discloses a routine equity grant: 534 shares issued as part of non-management director retainer fees. Such grants are standard practice to align non-employee directors with shareholder outcomes and to conserve cash compensation.

The filing explicitly ties the issuance to the non-management director compensation arrangement, showing governance-level alignment rather than an open-market purchase or sale.

Insider Activity Analyst

Transaction is a non-market issuance; ownership after the grant is 33,351 shares.

The reported transaction code and a $0 price indicate these shares were granted, not purchased. The Form 4 shows the reporting person's total beneficial ownership as 33,351 shares after the grant, a concrete ownership figure useful for monitoring insider holdings.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

MORRISON DENISE M

(Last) (First) (Middle)

METLIFE, INC.

200 PARK AVENUE

(Street)

NEW YORK NY 10166

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
METLIFE INC [ MET ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
10/01/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/01/2025		A(1)		534	A	$0	33,351	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock.

Remarks:

	/s/ Taylor McInerney Jansen, Attorney-in-fact	10/03/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Denise M. Morrison report on Form 4 for MET?

The Form 4 reports a non-derivative acquisition of 534 MetLife shares issued as director compensation, resulting in 33,351 shares beneficially owned.

When was the MET transaction executed and filed?

The transaction date is 10/01/2025 and the Form 4 was signed/dated on 10/03/2025.

Was the acquisition a market purchase or a grant?

The filing shows a price of $0 and an explanation that retainer fees are paid in stock, indicating this was a grant, not an open-market purchase.

What was the reason given for the stock issuance?

The filing states that MetLife's non-management director compensation arrangements pay a portion of retainer fees in common stock.

How many shares does the reporting person own after the transaction?

After the transaction the reporting person beneficially owns 33,351 shares of MetLife common stock.